The Safety and Efficacy of a SinuSonic Intervention
Completed · Not applicable
Conditions studied: Nasal Congestion
In brief
This study aims to test the safety and effectiveness of the SinuSonic device on adults with moderate to severe nasal congestion. SinuSonic is a medical device that utilizes sound and pressure combined with normal breathing to relieve nasal congestion. This device is held over the nose for 3 minutes. This study will use patient responses to measure how effective SinuSonic devices are in treating these moderate to severe congestion in adults. The study will consist of 40 subjects at the Medical University of South Carolina and will take place over the course of 4 to 6 weeks starting with a baseline assessment.
Key facts
- Study ID
- NCT03906968
- Run by
- Medical University of South Carolina
- People needed
- 40
- Starts
- 2019-03-31
- Expected to finish
- 2019-12-16
- Last updated by the study team
- 2021-04-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults ≥18 years of age
- Complaints of nasal congestion present for 2 weeks or more and a qualifying nasal congestion score of >5 (10 point VAS scale)
You may not qualify if…
- Fixed structural cause of nasal congestion (moderate or severe septal deviation, moderate or severe nasal valve collapse, Grade 3-4 polyp)
- Inability to read and understand English
- Allergic sensitivity to silicone or any other component of device
- History of severe nose bleeding within last 3 months
- Anticoagulation (Aspirin is acceptable)
- Known pregnancy
- Current nasal crusting or ulceration revealed on rhinoscopy
- Inability to perform treatment due to underlying medical condition
- Topical decongestant use in last week
Where it is running
- Sinus Center - Medical Univesity of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.